Sequenta Raises $13M
San Francisco-based Sequenta, a developer of a molecular diagnostics platform focused on immune system profiling, said today that it has raised $13M in a Series B funding round. The round came from Index Ventures, Mohr Davidow Ventures, and individual investor Jacob Goldfield. Sequenta said the funds will go towards development and commercialization of its products.
posted on Wednesday, December 8, 2010 (Link to more information)
Related companies:
Sequenta, Inc.
Related stories:
> Sequenta Secures $20M For Immune Therapeutics
> Sequenta Acquired By Adaptive Bio
> Artimi Raises $26.5M
> Barosense Raises $27.4M
> Twitter Raises $200M
silicontap.com Home